Corporate ActionJun 3, 2026, 08:31 AM
Conexeu Sciences to Ring Nasdaq Closing Bell on June 10
AI Summary
Conexeu Sciences Inc. announced it will ring the Nasdaq Closing Bell on June 10, 2026, to commemorate its recent public listing and the commencement of trading under the ticker symbol CNXU. President and CEO Miles Harrison will lead the ceremony, celebrating recent milestones such as the development of B.R.E.A.S.T. and the launch of a preclinical program. The biotechnology company focuses on advancing tissue regeneration through its proprietary CXU platform, targeting significant markets like wound care and body contouring.
Key Highlights
- Conexeu Sciences Inc. will ring the Nasdaq Closing Bell on June 10, 2026, to celebrate its recent public listing.
- President and CEO Miles Harrison will participate in the ceremony alongside board members, co-founders, and employees.
- The company recently developed BIO-REGENERATIVE ERGONOMICALLY ARCHITECTED SMART TISSUE (B.R.E.A.S.T.) using its CXU platform.
- Conexeu launched a preclinical development program at the Wake Forest Institute for Regenerative Medicine.
- The company is a preclinical-stage regenerative tissue platform company, focusing on restoring soft tissue.
- Conexeu targets wound care, periodontal applications, and facial/body contouring markets.
- An initial 510(k) submission for its lead device candidate, Ten Minute Tissue , is anticipated in early 2027.
Price Impact
More from CNXU